Murphy Capital Management’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $1.19M | Sell |
14,830
-86
| -0.6% | -$6.72K | 0.17% | 101 |
|
|
2022
Q1 | $1.13M | Sell |
14,916
-695
| -4% | -$55.1K | 0.13% | 110 |
|
|
2021
Q4 | $1.33M | Sell |
15,611
-325
| -2% | -$25.4K | 0.14% | 108 |
|
|
2021
Q3 | $1.2M | Sell |
15,936
-923
| -5% | -$73.3K | 0.14% | 105 |
|
|
2021
Q2 | $1.37M | Sell |
16,859
-171
| -1% | -$14K | 0.16% | 102 |
|
|
2021
Q1 | $1.34M | Sell |
17,030
-13
| -0.1% | -$1.02K | 0.17% | 99 |
|
|
2020
Q4 | $1.46M | Sell |
17,043
-763
| -4% | -$63.1K | 0.19% | 97 |
|
|
2020
Q3 | $1.37M | Buy |
17,806
+154
| +0.9% | +$11.7K | 0.2% | 95 |
|
|
2020
Q2 | $1.29M | Sell |
17,652
-250
| -1% | -$17.8K | 0.2% | 97 |
|
|
2020
Q1 | $1.19M | Sell |
17,902
-1,584
| -8% | -$112K | 0.23% | 98 |
|
|
2019
Q4 | $1.34M | Sell |
19,486
-265
| -1% | -$18.1K | 0.19% | 108 |
|
|
2019
Q3 | $1.45M | Sell |
19,751
-830
| -4% | -$60.2K | 0.22% | 104 |
|
|
2019
Q2 | $1.48M | Sell |
20,581
-661
| -3% | -$46.9K | 0.22% | 105 |
|
|
2019
Q1 | $1.46M | Sell |
21,242
-4,343
| -17% | -$281K | 0.22% | 110 |
|
|
2018
Q4 | $1.52M | Sell |
25,585
-1,625
| -6% | -$102K | 0.26% | 97 |
|
|
2018
Q3 | $1.82M | Sell |
27,210
-1,150
| -4% | -$76.6K | 0.25% | 95 |
|
|
2018
Q2 | $1.84M | Sell |
28,360
-1,750
| -6% | -$114K | 0.27% | 92 |
|
|
2018
Q1 | $2.16M | Sell |
30,110
-650
| -2% | -$46.8K | 0.31% | 87 |
|
|
2017
Q4 | $2.32M | Sell |
30,760
-1,075
| -3% | -$78.5K | 0.32% | 84 |
|
|
2017
Q3 | $2.32M | Sell |
31,835
-1,625
| -5% | -$117K | 0.33% | 81 |
|
|
2017
Q2 | $2.48M | Sell |
33,460
-600
| -2% | -$44.5K | 0.37% | 75 |
|
|
2017
Q1 | $2.49M | Buy |
34,060
+650
| +2% | +$45.5K | 0.37% | 73 |
|
|
2016
Q4 | $2.19M | Sell |
33,410
-825
| -2% | -$56.6K | 0.34% | 75 |
|
|
2016
Q3 | $2.54M | Sell |
34,235
-1,275
| -4% | -$94.3K | 0.39% | 69 |
|
|
2016
Q2 | $2.6M | Sell |
35,510
-450
| -1% | -$32K | 0.4% | 68 |
|
|
2016
Q1 | $2.54M | Sell |
35,960
-875
| -2% | -$58.2K | 0.4% | 62 |
|
|
2015
Q4 | $2.45M | Sell |
36,835
-1,242
| -3% | -$82.6K | 0.37% | 68 |
|
|
2015
Q3 | $2.42M | Sell |
38,077
-4,895
| -11% | -$320K | 0.4% | 65 |
|
|
2015
Q2 | $2.81M | Sell |
42,972
-2,370
| -5% | -$161K | 0.42% | 68 |
|
|
2015
Q1 | $3.14M | Sell |
45,342
-3,364
| -7% | -$233K | 0.46% | 58 |
|
|
2014
Q4 | $3.37M | Buy |
48,706
+1,400
| +3% | +$94.6K | 0.51% | 54 |
|
|
2014
Q3 | $3.08M | Buy |
47,306
+1,600
| +4% | +$106K | 0.48% | 59 |
|
|
2014
Q2 | $3.12M | Sell |
45,706
-150
| -0.3% | -$10.1K | 0.49% | 57 |
|
|
2014
Q1 | $2.97M | Sell |
45,856
-450
| -1% | -$28.4K | 0.5% | 57 |
|
|
2013
Q4 | $3.02M | Buy |
46,306
+550
| +1% | +$35.2K | 0.52% | 57 |
|
|
2013
Q3 | $2.71M | Buy |
45,756
+4,860
| +12% | +$288K | 0.51% | 59 |
|
|
2013
Q2 | $2.34M | Buy |
+40,896
| New | +$2.43M | 0.48% | 64 |
|
Other funds holding CL
Murphy Capital Management's CL Position: Q2 2022 in Review
Murphy Capital Management reduced its Colgate-Palmolive (CL) stake by 0.58% in Q2 2022, selling an estimated $6.72K and leaving 14,830 shares worth $1.19M. The position accounts for 0.17% of the portfolio, ranked #101.
Murphy Capital Management first reported a position in CL in Q2 2013 and has held it in 37 quarters since. The position peaked at $3.37M in Q4 2014. 1,668 funds tracked by Wall St. Rank hold CL as of Q2 2022.
- Murphy Capital Management held 14,830 shares of Colgate-Palmolive worth $1.19M as of Q2 2022.
- Murphy Capital Management sold 86 Colgate-Palmolive shares in Q2 2022, an estimated $6.72K.
- Colgate-Palmolive made up 0.17% of Murphy Capital Management's portfolio in Q2 2022, its #101 holding.
- Murphy Capital Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 37 quarters since.
- Murphy Capital Management's Colgate-Palmolive position peaked at $3.37M in Q4 2014.
- 1,668 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2022.
Based on Murphy Capital Management's 13F filing for Q2 2022, filed 13 Jul 2022.